Floatz logo

ETOPOSIDE

Adult Oligodendroglioma

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversitySmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Adult Oligodendroglioma cohort.

Asset / SponsorPhaseRating
Cediranib
Lawrence Recht
Phase 2BB
su011248
National Cancer Institute (NCI)
Phase 2B
Tas-102
National Cancer Institute (NCI)
Phase 2B
Perifosine
National Cancer Institute (NCI)
Phase 1/2CCC
Temsirolimus
National Cancer Institute (NCI)
Phase 1/2CCC

View all 19 →

Same molecule, other indications

ETOPOSIDE is also rated in:

acute megakaryoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
acute monocytic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
acute myeloblastic leukemia with maturationDormant
BBB
Indicative ·
79 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →